Smoking after Coronary Artery Bypass: High Three-Year Mortality

 

 Buy Article Permissions and Reprints All articles of this category

Abstract

Background: Coronary artery bypass grafting (CABG) is carried out for prognosis and symptomatic relief. Smoking is associated with increased postoperative complications, although its precise influence on long-term survival is unclear. We examined the influence of smoking and other risk factors on survival and myocardial ischaemia seven years after CABG.

Methods: 208 patients underwent elective CABG; 25 % were persistent smokers. 165 were alive at seven years. 128 (78 % of survivors) agreed to reexamination and 79 had thallium scans.

Results: Angina and dyspnoea were reported by 52 % and 69 %, respectively, of survivors; these were associated with smoking (p = 0.029 and 0.0 009) but with no other risk factors. Smokers had higher stress thallium scores (p = 0.057) and ischaemia scores (10.6 ± 6.5 vs. 6.8 ± 6.0; p = 0.036); ejection fractions were equivalent. Obesity was prevalent and worsened in men. 33 patients (17 %) died during follow-up. Initially there was no survival difference between smokers and nonsmokers but as early as three years postoperation smoking was associated with an increased mortality (p = 0.011; log-rank test).

Conclusions: Patients experienced almost universal improvement with the operation. However, persistent smoking completely removed the prognostic benefits of CABG by accelerating late mortality which was higher than previously reported. Higher indices of ischaemia in smokers were suggested by symptoms and confirmed by perfusion scans.

References

• 1 National Institute of Health Consensus . Development conference statement: coronary artery bypass surgery; scientific and clinical aspects.  N Engl J Med. 1981;  304 680-684
  PubMedGoogle Scholar
• 2 Alderman E L, Corley S D, Fisher L D. et al . Five year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS participating investigators and staff.  J Am Coll Cardiol. 1993;  22 1141-1154
  PubMedGoogle Scholar
• 3 Lindsay G M, Smith L N, Hanlon P, Wheatley D J. The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting.  Heart. 2001;  85 80-86
  CrossrefPubMedGoogle Scholar
• 4 Belcher P R, Gaw A, Cooper M, Brown M, Wheatley D J, Lindsay G M. Are we negating the benefits of coronary artery bypass grafting?.  J Human Hypertens. 2002;  16 691-697
  PubMedGoogle Scholar
• 5 Lindsay G M, Hanlon W P, Smith L N, Belcher P R. Experience of cardiac rehabilitation after coronary artery surgery: effects on health and risk factors.  Int J Cardiol. 2002;  87 67-73
  PubMedGoogle Scholar
• 6 Tolmie E P, Lindsay G M, Belcher P R. Coronary artery bypass graft operation: patients' experience of health and well-being over time.  Eur J Cardiovasc Nursing. 2006;  5 228-236
  PubMedGoogle Scholar
• 7 Scott J, Huskisson E C. Graphic representation of pain.  Pain. 1976;  2 175-184
  CrossrefPubMedGoogle Scholar
• 8 Martin W, Tweddle A C, McGhie A I, Hutton I. Gated thallium scintigraphy in patients with coronary artery disease: an improved planar imaging technique.  Clin Phys Physiol Meas. 1987;  8 343-354
  CrossrefPubMedGoogle Scholar
• 9 Simons L A, Simons J, Parfitt A. Coronary risk factors 6–12 months after coronary artery bypass grafting. Comparison of surveys in 1986, 1990 and 1994.  Med J Aust. 1994;  161 536-537
  PubMedGoogle Scholar
• 10 Herlitz J, Haglid M, Albertsson P. et al . Short- and long-term prognosis after coronary artery bypass grafting in relation to smoking habits.  Cardiology. 1997;  88 492-497
  CrossrefPubMedGoogle Scholar
• 11 McLeod A L, Brooks L, Taylor V, Currie P F, Dewhurst N G. Secondary prevention for coronary artery disease.  QJM. 2004;  97 127-131
  CrossrefPubMedGoogle Scholar
• 12 van Domburg R T, Meeter K, van Berkel D F, Veldkamp R F, van Herwerden L A, Bogers A J. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study.  J Am Coll Cardiol. 2000;  36 878-883
  CrossrefPubMedGoogle Scholar
• 13 Hilleman D E, Mohiuddin S M, Packard K A. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery.  Chest. 2004;  125 435-438
  CrossrefPubMedGoogle Scholar
• 14 Ilia R, Carmel S, Carlos C, Gueron M. Relation between shortness of breath, left ventricular end diastolic pressure and severity of coronary artery disease.  Int J Cardiol. 1995;  52 153-155
  CrossrefPubMedGoogle Scholar
• 15 Baskett R J, Buth K J, Collicott C, Ross D B, Hirsch G M. Preoperative cardiovascular risk factor control in elective coronary artery bypass graft patients: a failure of present management.  Can J Cardiol. 2002;  18 397-402
  PubMedGoogle Scholar
• 16 Herlitz J. Secondary prevention after coronary artery bypass grafting – what do we know?.  Scand Cardiovasc J. 2004;  38 69-74
  CrossrefPubMedGoogle Scholar
• 17 Sever P, Beevers G, Bulpitt C. et al . Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.  Br Med J. 1993;  306 983-987
  PubMedGoogle Scholar
• 18 Burt V L, Whelton P, Roccella E J, Brown C, Cutler J A, Higgins M, Horan M J, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991.  Hypertension. 1995;  25 305-313
  Google Scholar
• 19 Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.  Atherosclerosis. 1998;  140 199-270
  CrossrefPubMedGoogle Scholar
• 20 Lean M E, Han T S, Seidell J C. Impairment of health and quality of life in people with large waist circumference.  Lancet. 1998;  351 853-856
  CrossrefPubMedGoogle Scholar
• 21 Emberson J R, Whincup P H, Lawlor D A, Montaner D, Ebrahim S. Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women.  Heart. 2005;  91 451-455
  CrossrefPubMedGoogle Scholar
• 22 and Group; European Action on Secondary Prevention by Intervention to Reduce Events E UROASPIREIII. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.  Lancet. 2001;  357 995-1001
  CrossrefPubMedGoogle Scholar
• 23 Brady A J, Oliver M A, Pittard J B. Secondary prevention in 24 431 patients with coronary heart disease: survey in primary care.  Br Med J. 2001;  322 1463
  PubMedGoogle Scholar
• 24 Bradshaw P J, Jamrozik K, Gilfillan I, Thompson P L. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.  Am Heart J. 2004;  147 1047-1053
  CrossrefPubMedGoogle Scholar
• 25 Singer D E, Albers G W, Dalen J E, Go A S, Halperin J L, Manning W J. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 (Suppl. 3) 429S-456S
  CrossrefPubMedGoogle Scholar
• 26 Cox J, Naylor C D. The Canadian Cardiovascular Society grading scale for angina pectoris: is it time for refinements?.  Ann Intern Med. 1992;  117 677-683
  PubMedGoogle Scholar
• 27 Asakuma S, Fujiwara M, Ohyanagi M, Iwasaki T. A simple reliable method of assessing exercise capacity in patients with chronic heart failure.  Med Sci Sports Exerc. 1999;  31 52-56
  PubMedGoogle Scholar
• 28 Lindsay G M, Tolmie E M, Brodie E, Niven C A, Belcher P R. Accuracy of patient recall of symptoms post-CABG.  J Clin Nursing.
  PubMedGoogle Scholar

MD, FRCS Philip R. Belcher

University of Glasgow
Cardiac Surgery

Wolfson Medical School Building, University Avenue

G12 8QQ Glasgow

United Kingdom

Phone: + 44 14 13 30 80 46

Fax: + 44 14 13 30 27 76

Email: pbelcher@clinmed.gla.ac.uk